Copyright
©The Author(s) 2016.
World J Dermatol. May 2, 2016; 5(2): 72-83
Published online May 2, 2016. doi: 10.5314/wjd.v5.i2.72
Published online May 2, 2016. doi: 10.5314/wjd.v5.i2.72
Disease | Observations |
Allergic contact dermatitis | Increased P2X7 expression in atopic dermatitis lesions[88] |
Irritant contact dermatitis | ND |
Psoriasis | Increased P2X7 expression in psoriatic skin lesions[30,88] |
Cutaneous graft-vs-host disease | ND |
Wound healing | P2X7 activation promotes VEGF release from monocytes[103] |
Skin transplantation | ND |
Melanoma | P2X7 is present on melanoma cells[117,118] and cell lines[119], with increased expression compared to normal melanocytes[119] |
P2X7 activation induces A375 melanoma[118] but suppresses HT168-M1 melanoma cell death[119] | |
Basal cell carcinoma | P2X7 is present in necrotic tumour centres and apoptotic tumour cells, and correlates inversely with tumour aggressiveness[123] |
Squamous cell carcinoma | P2X7 is present in apoptotic tumour cells and its activation causes A431 SCC cell death[123] |
- Citation: Geraghty NJ, Watson D, Adhikary SR, Sluyter R. P2X7 receptor in skin biology and diseases. World J Dermatol 2016; 5(2): 72-83
- URL: https://www.wjgnet.com/2218-6190/full/v5/i2/72.htm
- DOI: https://dx.doi.org/10.5314/wjd.v5.i2.72